Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers

Clinical Infectious Diseases

Volumn 43, Issue 6, 2006, Pages 673-679

  Hill, Philip C ^a   Akisanya, Abiodun ^a   Sankareh, Kawsu ^a   Cheung, Yin Bun ^b   Saaka, Mark ^a   Lahai, George ^a   Greenwood, Brian M ^b   Adegbola, Richard A ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILD; FEMALE; GAMBIA; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL POPULATION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; GAMBIA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASOPHARYNX; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 33748294182     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/506941     Document Type: Article

References (36)

1. Greenwood B. The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B 1999; 354:777-85.
2. Leowski J. Mortality from acute respiratory infections in children under 5 years of age: global estimates. World Health Stat Q 1986; 39:138-44.
3. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003; 362:355-61.
4. Klugman KP, Madhi SA, Huebner RE, et al. A trial of 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-48.
5. Cutts FT, Zaman SMA, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double blind, placebo-controlled trial. Lancet 2005; 365:1139-46.
6. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-46.
7. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonvalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centres. Pediatr Infect Dis J 2003; 22:532-40.
8. Ghaffar F, Barton T, Lozano J, et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis 2004; 39:930-8.
9. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005; 41:21-9.
10. Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infections during the first 24 months of life. J Infect Dis 1980; 142:923-33.
11. Syrjären RK, Auranen KJ, Leino TM, Kilpi TM, Mäkelä PH. Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage. Pediatr Infect Dis J 2005; 24:801-6.
12. Schim van der Loeff MF, Sarge-Njie R, Ceesay S, et al. Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. AIDS 2003; 17:1841-6.
13. O'Brien KL, Nohynek H. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003; 22:133-40.
14. Brueggemann AB, Griffiths DT, Meats E, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187:1424-32.
15. Saha SK, Baqui AH, Darmstadt GL, et al. Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol 2003; 41:5582-7.
16. Montgomery JM, Lehmann D, Smith T, et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea. Rev Infect Dis 1990; 12:S1006-16.
17. Lloyd-Evans N, O'Dempsey TJD, Baldeh I, et al. Nasopharyngeal carriage of pneumococci in Gambian children and their families. Pediatr Infect Dis J 1996; 15:866-71.
18. Soewignjo S, Gessner BD, Sutanto A, et al. Streptococcus pneumoniae nasopharyngeal carriage prevalence, serotype distribution, and resistance patterns among children on Lombok Island, Indonesia. Clin Infect Dis 2001; 32:1039-43.
19. Mastro TD, Nomani NK, Ishaq Z. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J 1993; 12:824-30.
20. Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 2004; 38:632-9.
21. Marchisio P, Esposito S, Schito GC, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. Emerg Infect Dis 2002; 8:479-84.
22. Principi N, Marchisio P, Schito GC, Mannelli S, Ascanius Project Collaborative Group. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Pediatr Infect Dis J 1999; 18:517-23.
23. Syrjänen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis 2001; 181:451-9.
24. Huang SS, Finkelstein JA, Rifas-Shiman SL, Kleinman K, Platt R. Community-level predictors of pneumococcal carriage and resistance in young children. Am J Epidemiol 2004; 159:645-54.
25. Fairchok MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates. Clin Infect Dis 1996; 22:966-72.
26. Hendley JO, Sande MA, Stewart PM, Gwaltney JM. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis 1975; 132:55-61.
27. Ussery XT, Bradford D, Gessner MD, et al. Risk factors for nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska. Pediatr Infect Dis J 1996; 15:986-92.
28. Gratten M, Gratten H, Poly A, et al. Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage and relationship to carriage in mothers. Biol Neonate 1986; 50:114-20.
29. Yagupsky P, Porat N, Fraser D, et al. Acquisition, carriage and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 1998; 177:1003-12.
30. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B. Post-vaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. Active Bacterial Core Surveillance Team. J Infect Dis 2005; 192:1988-95.
31. Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis 2006; 42:907-14.
32. Sandgren A, Sjöström K, Olsson-Liljequist B, et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 2004; 189:785-96.
33. Adegbola RA, Hill PC, Secka O, et al. Serotype and anti-microbial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 2006; 11:1128-35.
34. Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993; 111:27-39.
35. Sazawal S, Black RE, Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003; 3:547-56.
36. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354:1455-63.